J
Julie M. Vose
Researcher at University of Nebraska Medical Center
Publications - 569
Citations - 51589
Julie M. Vose is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Transplantation & Lymphoma. The author has an hindex of 97, co-authored 541 publications receiving 46915 citations. Previous affiliations of Julie M. Vose include Memorial Hospital of South Bend.
Papers
More filters
Journal ArticleDOI
Outcomes of Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).
John D. Dickinson,Fausto R. Loberiza,Victoria Whalen,Philip J. Bierman,Julie M. Vose,Marcel P. Devetten,Lori J. Maness,James O. Armitage,Greg Bociek +8 more
TL;DR: CLL/SLL patients undergoing allogeneic SCT had a higher incidence of early treatment related mortality, mainly from regimen related toxicity and infection and a subgroup analysis suggests pts with CLL appear to have an inferior PFS compared with pts with SLL.
Journal ArticleDOI
Outcome of Limited-Stage Peripheral T-Cell Lymphoma: Results from the Nebraska Lymphoma Study Group.
Philip J. Bierman,Julie M. Vose,R. Gregory Bociek,Fausto R. Loberiza,Martin Bast,Dennis D. Weisenburger,James O. Armitage +6 more
TL;DR: A retrospective review of patients with limited-stage peripheral T-cell lymphoma who were identified in the database of the Nebraska Lymphoma Study Group found no significant differences in the risk of treatment failure or death when the influence of histology, stage, and type of treatment was considered.
Journal ArticleDOI
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
N. Nora Bennani,N. Nora Bennani,Aung M. Tun,Kenneth R. Carson,Jessica L. Geiger,Lauren S. Maeda,Kerry J. Savage,Jim Rose,Lauren Pinter-Brown,Matthew A. Lunning,Jeremy S. Abramson,Nancy L. Bartlett,Julie M. Vose,Andrew M. Evens,Sonali M. Smith,Steven M. Horwitz,Stephen M. Ansell,Ranjana H. Advani +17 more
TL;DR: In this paper, the authors assessed characteristics and outcomes of patients with extranodal natural killer/T-cell lymphoma (ENKTL) from major North American centers and found that the majority of patients presented with early stage disease.
Journal ArticleDOI
Long term disease free survival in patients with mantle cell lymphoma following hematopoietic stem cell transplantation
Apar Kishor Ganti,P. J. Bierman,James C. Lynch,Robert G. Bociek,Julie M. Vose,James O. Armitage +5 more
Journal ArticleDOI
Association of Increased Thymidine Uptake Relative to Tumor Cell Proliferation in Low-Grade Follicular Lymphoma and DNA Repair.
Malik E. Juweid,Sergei Syrbu,Michelle Bleile,Andreas K. Buck,Marielle J. Wondergem,Julie M. Vose +5 more
TL;DR: Interestingly, similar staining pattern to that seen in lymphoma samples was seen in germinal center but not mantle zone cells of normal tonsils and reactive lymph nodes indicating that the DNA repair seen in both FL and DLBCL is likely related to somatic hypermutations generated by error-prone DNA repair.